621
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Can reproductive pattern explain better survival of women with lung cancer?

&
Pages 47-53 | Received 24 May 2005, Published online: 08 Jul 2009

References

  • Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003; 21: 3035–40
  • Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol 2003; 14(Suppl 5)V61–V118
  • Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2003; 8(6)541–52
  • Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341: 1198–205
  • de Perrot M, Licker M, Bouchardy C, Usel M, Robert J, Spiliopoulos A. Sex differences in presentation, management, and prognosis of patients with non–small cell lung carcinoma. J Thorac Cardiovasc Surg 2000; 119: 21–6
  • O'Connell J, Kris MG, Gralla RJ, Groshen S, Trist A, Fiore JJ, et al. Frequency and prognostic importance of pre-treatment clinical characteristics in patients with advanced non–small cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986; 4: 1604–14
  • Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non–small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991; 9: 1618–26
  • Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival: population based study of 20 561 cases. Ann Oncol 2002; 13: 1087–93
  • Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR, Ihde DC. Female patients with small cell lung cancer live longer than male patients. Am J Med 1988; 85: 194–6
  • Kris M, Natale R, Herbst R, Lynch TT, Jr, Prager D, Belani CP, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer. JAMA 2003; 290: 2149–58
  • Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small cell lung cancer. J Clin Oncol 2003; 21: 2237–46
  • Alexiou C, Onyeaka CV, Beggs D, Akar R, Beggs L, Salama FD, et al. Do women live longer following lung resection for carcinoma?. Eur J Cardiothorac Surg 2002; 21: 319–25
  • Ferguson MK, Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival?. J Thorac Cardiovasc Surg 2000; 119: 440–8
  • Skuladottir H, Olsen JH, Hirsch FR. Incidence of lung cancer in Denmark: historical and actual status. Lung Cancer 2000; 27: 107–18
  • Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, et al. Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999; 91: 675–90
  • Wynder EL, Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 1994; 54: 5284–95
  • Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002; 188: 125–40
  • World Health Organization. International classification of diseases for oncology (ICD-O). World Health Organization, Geneva 1976
  • Krasnik M, Frølund CHL, Rosenstock SJ, Franzmann M-B, Storm HH. Forekomsten af lungekræft i Danmark 1943–1986. Cancerregisterets pålidelighed. Ugeskr Laeg 1994; 156: 3021–5
  • World Health Organization. Histologic typing of lung cancer2nd ed. World Health Organization, Geneva 1981
  • Danish Ministry of Interior Affairs and Health. Civil registration system in Denmark. Copenhagen: Central Office of Civil Registration; 2001 ( http://www.cpr.dk/).
  • Westergaard, T. Birth order and cancer risk. Ph. D thesis, University of Copenhagen, 1997.
  • Statistics Denmark. Statistical Yearbook 2003. Copenhagen: Statistics Denmark; 2003. ( http://www.dst.dk/HomeUK/Statistics/Publications/Yearbook/2003.aspx)
  • James WH. Evidence that mammalian sex ratios at birth are partially controlled by parental hormone levels at the time of conception. J Theor Biol 1996; 180: 271–86
  • Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988; 52: 69–83
  • Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle aged men: a 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997; 146: 609–17
  • Bain C, Feskanich D, Speizer FE, Thun MJ, Hertzmark E, Rosner BA, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004; 96: 826–34
  • Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, et al. Lung cancer among Chinese women. Int J Cancer 1987; 40: 604–9
  • Seow A, Poh WT, Teh M, Pike MC, Henderson BE, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002; 97: 365–71
  • Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994; 86: 869–70
  • Wu-Williams AH, Dai XD, Blot WJ. Lung cancer among women in north-east China. Br J Cancer 1990; 62: 982–7
  • Wu AH, Yu MC, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988; 48: 7279–84
  • Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833–9
  • Ettinger B, Friedman GD, Bush T, Quesenberry CP, Jr. Reduced mortality associated with long term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87: 6–12
  • Kreuzer M, Gerken M, Heinrich J, Krienbrocn L, Wickmann ME. Hormonal factors and risk of lung cancer among women?. Int J Epidemiol 2003; 32: 263–71
  • Moore KA, Mery CM, Jaklitsch MT, Estocin AP, Bnend R, Swanson SJ, et al. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg 2003; 76: 1789–95
  • Johnston EM, McIntyre LM, Hoff JA, Bepler G. The effect of orchiectomy on lung cancer survival. Anticancer Res 1999; 19: 5567–70
  • de Perrot M, Licker M, Bouchardy C, Usel M, Robert J, Spiliopoulos A. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2000; 119: 21–6
  • Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival. the role of comorbidity and treatment. Chest 2004; 125: 27–37
  • Henson DE, Ries LA. The relative survival rate. Cancer 1995; 76: 1687–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.